Kingdon Capital Management, L.L.C. Imago Bio Sciences, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$11.81 - $20.92 $3.07 Million - $5.44 Million	-260,118 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.97 - $25.0 $1.46 Million - $2.16 Million	86,288 Added 49.64%	260,118 $5.01 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $2.78 Million - $5.01 Million	173,830 New	173,830 $3.48 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.